Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Poster Session 02

Tuesday 04/15/08
11:30 AM - 02:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neurotoxicology, MS and Related Diseases, Neuroepidemiology/Health Services and Outcomes Research, Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Aging and Dementia, Epilepsy, Epilepsy/Clinical Neurophysiology (EEG), Muscle Disease/Neuromuscular Junction
No CME available
Event Timeline
11:30 AM - 02:30 PM Abstract 001 - Development of a Screening Instrument To Estimate the Prevalence of Neurological Morbidity in an African Setting
11:30 AM - 02:30 PM Abstract 002 - Neurological Disorders in Rural Africa - Suggestion of a Clinical Algorithm
11:30 AM - 02:30 PM Abstract 003 - Mild Parkinsonian Signs and Parkinson's Disease in a Population of Nonagenarians
11:30 AM - 02:30 PM Abstract 004 - Mechanisms, Risk Factors and Imaging Patterns of Ischemic Stroke in Cocaine Users
11:30 AM - 02:30 PM Abstract 005 - Pulmonary Embolism after Hemispheric and Brainstem Ischemic Stroke: Autopsy-Based Study
11:30 AM - 02:30 PM Abstract 006 - Unilateral Pseudotumoral Presentation of Cerebral Venous Thrombosis: Report of Two Cases
11:30 AM - 02:30 PM Abstract 007 - The Effect of Fasting on Cerebral Venous and Dural Sinus Thrombosis
11:30 AM - 02:30 PM Abstract 008 - Do Stroke and TIA Hurt?
11:30 AM - 02:30 PM Abstract 009 - The Patterns and Plausible Mechanisms of Cerebral Infarction Associated with Coronary Angiography
11:30 AM - 02:30 PM Abstract 010 - Clinical Presentation, Treatment, and Outcome of 131 Patients with Cerebral Artery Dissection
11:30 AM - 02:30 PM Abstract 011 - The Dolichosis of the Vertebral Artery and the Medullary Compression by Vertebral Artery, Symptomatic?
11:30 AM - 02:30 PM Abstract 012 - Ischemic Stroke of the Cortical "Hand Knob" Area: Pathomechanisms and Clinical Course
11:30 AM - 02:30 PM Abstract 013 - Hemimedullary Syndrome with Ipsilateral Sensorimotor Deficit: A Right Vertebral Dissection Syndrome
11:30 AM - 02:30 PM Abstract 014 - New Version of the UPDRS (MDS-UPDRS): Factor Analysis
11:30 AM - 02:30 PM Abstract 015 - What Parkinson's Disease Subtypes Are Associated with Greatest Disability?
11:30 AM - 02:30 PM Abstract 016 - Comparison of Kinesia[trade] to the Unified Parkinson's Disease Rating Scale: Tremor and Bradykinesia Results
11:30 AM - 02:30 PM Abstract 017 - Evaluating Parkinson's Disease Patients at Home: Utility of Self-Videotaping for Objective Motor, Dyskinesia and ON/OFF Assessments
11:30 AM - 02:30 PM Abstract 018 - Parkinson's Disease At-Home Testing Device: Feasibility and Relationship to UPDRS Changes over Six Months
11:30 AM - 02:30 PM Abstract 019 - The Angular Rate Measurement Devices for Quantitative Grading the Motor Function in Idiopathic Parkinson's Disease
11:30 AM - 02:30 PM Abstract 020 - Stereoacuity and Contrast Sensitivity Do Not Affect Freezing of Gait in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 021 - Correlating Upper Extremity and Lower Extremity Motor Impairment in Parkinson Disease to Quality of Life: Which Has the Stronger Influence?
11:30 AM - 02:30 PM Abstract 023 - What Is the Role of Spirituality or Religiosity in Parkinson's Disease?
11:30 AM - 02:30 PM Abstract 024 - Once-Daily Ropinirole 24-Hour Prolonged Release as Adjunct to L-dopa Delays the Onset of Dyskinesia Compared with Carbidopa/Levodopa in Patients with Parkinson's Disease
11:30 AM - 02:30 PM Abstract 025 - Safety and Tolerability of Tyramine Challenge in Levodopa-Treated Parkinson's Disease (PD) Patients Receiving Rasagiline
11:30 AM - 02:30 PM Abstract 026 - Pharmacokinetics and Pharmacodynamics of Novel Levodopa Formulations Combining Immediate- and Extended-Release Components (VADOVA): Comparisons to Sinemet and Sinemet CR in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 027 - Evaluation of Open-Label Rotigotine Treatment in Advanced Parkinson's Disease
11:30 AM - 02:30 PM Abstract 028 - Pardoprunox (SLV308) Improves Motor Symptoms in Patients with Early Stage Parkinson's Disease (PD) - A Double-Blind Placebo-Controlled Multi-Center Study
11:30 AM - 02:30 PM Abstract 029 - Effect of Medication Washout on Motor Function in Early Stage Parkinson's Disease
11:30 AM - 02:30 PM Abstract 030 - LEGATO: Early Rapid Clinical Benefit with Azilect[reg] (Rasagiline Tablets) as Mono- and Adjunct Therapy on Parkinson's Disease (PD) Symptoms - A Multicenter Phase IV Trial
11:30 AM - 02:30 PM Abstract 031 - Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Modeling of Istradefylline
11:30 AM - 02:30 PM Abstract 033 - Adherence to Rotigotine Treatment in 100 Patients
11:30 AM - 02:30 PM Abstract 034 - Diffusion MRI Changes and the Clinical Course of Steroid Responsive Encephalopathy: A Case Report
11:30 AM - 02:30 PM Abstract 035 - Neurologic Complications of Lung Transplantation
11:30 AM - 02:30 PM Abstract 036 - FDG PET for the Patients with CNS Sarcoidosis and Sarcoidmyositis
11:30 AM - 02:30 PM Abstract 037 - Central Nervous System Demyelination in Diabetes
11:30 AM - 02:30 PM Abstract 038 - Diffusion Weighted Magnetic Resonance Imaging in Mitochontrial Encephalopathy
11:30 AM - 02:30 PM Abstract 039 - Changes in Cerebral Perfusion and Tissue Oxygenation Due to Occlusion of External Carotid Artery
11:30 AM - 02:30 PM Abstract 040 - West Nile Encephalitis Associated with Reversible Restricted Diffusion of Splenium of Corpus Callosum
11:30 AM - 02:30 PM Abstract 041 - Prolonged Cognitive Dysfunction after Recurrent Hypoglycemia
11:30 AM - 02:30 PM Abstract 042 - ALS-Mimic Syndrome in a Patient with High Level of Antiphospholipid Antibody: A Case Report
11:30 AM - 02:30 PM Abstract 043 - Acute Delirium Due to Hypercalcemia as a Presenting Manifestation of Pulmonary Sarcoidosis: A Case Report
11:30 AM - 02:30 PM Abstract 044 - Diffusion Weighted MR Image Findings in Patients with Hypoglycemia
11:30 AM - 02:30 PM Abstract 045 - Central Nervous System Involvement in Systemic Lupus Erythematosus: Magnetic Resonance Imaging and Cerebrospinal Fluid Analysis
11:30 AM - 02:30 PM Abstract 046 - Quantitative MRI Analysis and Clinical Significance of Hyperintense White Matter Lesions in SLE Patients
11:30 AM - 02:30 PM Abstract 047 - The Neurocardiac Manifestations in the Left Atrial Myxoma
11:30 AM - 02:30 PM Abstract 048 - Successful Treatment of Cognitive Decline in Sneddon Syndrome Associated with Hepatitis C with Cyclophosphamide
11:30 AM - 02:30 PM Abstract 049 - Electrophysiologic Features of Carpal Tunnel Syndrome Associated with Amyloidosis
11:30 AM - 02:30 PM Abstract 050 - Clinical Study of 35 Patients with Sensory Neuropathy and Impaired Glucose Tolerance
11:30 AM - 02:30 PM Abstract 051 - Ischemic Stroke as the Initial Presentation of Churg-Strauss Syndrome
11:30 AM - 02:30 PM Abstract 052 - The Differential Diagnosis of Isolated Angiitis of the CNS (IAN) and Bacterial Endocarditis (BE)
11:30 AM - 02:30 PM Abstract 053 - Psoriatic Arthritis-Associated Painful Small Fiber Neuropathy
11:30 AM - 02:30 PM Abstract 054 - Zarit Burden Inventory and Activities of Daily Living in the Behavioral Variant of Frontotemporal Dementia
11:30 AM - 02:30 PM Abstract 055 - Depression and Environmental Factors in Alzheimer Disease in Spain (IDEAL Study). Preliminary Results
11:30 AM - 02:30 PM Abstract 056 - Depression Significant in Community-Dwelling Chinese Patients Referred for Subspecialty Dementia Evaluation
11:30 AM - 02:30 PM Abstract 057 - Survival Analysis of Patients with Cognitive Impairment and Subtypes of Dementia from a Specialized Dementia Clinic
11:30 AM - 02:30 PM Abstract 058 - Anxiety and Apathy Are Associated with Probable REM Sleep Behavior Disorder among Cognitively Normal Elderly Subjects: The Mayo Clinic Study of Aging
11:30 AM - 02:30 PM Abstract 059 - Cognitive Functions in Chronic Inflammatory Demyelinating Polyneuropathy
11:30 AM - 02:30 PM Abstract 060 - Frontotemporal Lobar Degeneration and Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 061 - Progression of MCI to Dementia in Clinic Versus Community Based Cohorts
11:30 AM - 02:30 PM Abstract 062 - Twinkle-Twinkle Little Star to Beethoven: A Reversible Immune-Mediated Dementia
11:30 AM - 02:30 PM Abstract 063 - Outcomes of Uncertain Dementia
11:30 AM - 02:30 PM Abstract 064 - The VISN 23 Dementia Demonstration Project
11:30 AM - 02:30 PM Abstract 065 - Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease in Illiterate and Low-Educated Patients
11:30 AM - 02:30 PM Abstract 066 - Evaluation of the Usefulness of Self-Reported Memory Decline in a Longitudinal Study of Aging and Cognition
11:30 AM - 02:30 PM Abstract 067 - Basal Ganglia MRI Hyperintensities and Falls in Community-Dwelling Elderly
11:30 AM - 02:30 PM Abstract 068 - Detecting Dementia in Ecuador Using the AD8 and CDR Evaluations
11:30 AM - 02:30 PM Abstract 069 - Demographic and Etiologic Characteristics of Young-Onset Dementia
11:30 AM - 02:30 PM Abstract 070 - Epilepsy and Motor Vehicle Driving in Argentina
11:30 AM - 02:30 PM Abstract 071 - Sexual Dysfunction in Women with Epilepsy
11:30 AM - 02:30 PM Abstract 072 - Cost of Antiepileptic Drug (AED) Usage in Patients with Pseudo-Seizure Disorders
11:30 AM - 02:30 PM Abstract 073 - The Head Nodding Syndrome - Clinical Classification and Possible Causes of a New Epilepsy Disorder
11:30 AM - 02:30 PM Abstract 074 - Economic Impact of Non-Epileptic Seizures on the Health Care System and the Importance of Their Early Diagnosis and Treatment
11:30 AM - 02:30 PM Abstract 075 - Screening for Folate Use in Women of Childbearing Potential with Epilepsy
11:30 AM - 02:30 PM Abstract 076 - Injuries in Pharmacoresistant Epilepsy: A Comparison of Temporal and Extratemporal Epilepsy Patients
11:30 AM - 02:30 PM Abstract 077 - The Executive Function on the Wisconsin Card Sorting Test in Patients with Mesial Temporal Lobe Epilepsy
11:30 AM - 02:30 PM Abstract 078 - Practical Ambulatory Screening for Depression in Epilepsy Using Two Screening Instruments
11:30 AM - 02:30 PM Abstract 079 - Interictal Mood Disorder and Quality of Life in Medically Refractory Epilepsy
11:30 AM - 02:30 PM Abstract 081 - Risk Factors for Increase in Troponin after Epileptic Seizures in Emergency Room Patients
11:30 AM - 02:30 PM Abstract 082 - Relations of Serum ACTH COR and Sleep Seizures
11:30 AM - 02:30 PM Abstract 083 - Time to Diagnosis of Pseudo-Seizures by Audio-Video EEG (AVEEG) Monitoring: A Retrospective Analysis
11:30 AM - 02:30 PM Abstract 084 - Epilepsy and Arachnoid Cysts in Children
11:30 AM - 02:30 PM Abstract 085 - Seizure Outcome after Change of Antiepileptic Drug in Seizure-Free and Non-Seizure-Free Patients
11:30 AM - 02:30 PM Abstract 086 - In-Hospital Complications of Epilepsy Surgery: A Six-Year Nationwide Experience
11:30 AM - 02:30 PM Abstract 087 - Effect of Longterm Antiepileptic Drug Therapy on Lipid Profile
11:30 AM - 02:30 PM Abstract 088 - Lamotrigine-Valproic Acid Combination Therapy for Medically Refractory Epilepsy
11:30 AM - 02:30 PM Abstract 089 - Verapamil in Refractory Status Epilepticus - A Case Report
11:30 AM - 02:30 PM Abstract 090 - Pregabalin Add-On Treatment Using a Flexible, Optimized Dose Schedule in Asian Subjects with Partial Seizures
11:30 AM - 02:30 PM Abstract 091 - Intravenous Levetiracetam: A New Treatment Alternative for Status Epilepticus
11:30 AM - 02:30 PM Abstract 092 - Once-Daily Extended-Release Levetiracetam as Add-On Therapy in Patients with Refractory Partial-Onset Seizures: Double Blind, Placebo-Controlled Trial
11:30 AM - 02:30 PM Abstract 093 - Variables Associated with Weight Gain during Treatment with Pregabalin for Epilepsy
11:30 AM - 02:30 PM Abstract 094 - Exploratory Assessment of Behavioral and Emotional Function in Children and Adolescents with Partial-Onset Seizures Treated with Adjunctive Levetiracetam in a Randomized Placebo-Controlled Trial
11:30 AM - 02:30 PM Abstract 095 - A Head to Head Comparison of Pregabalin and Lamotrigine, Including a Third Placebo Arm, as Adjunctive Therapy in Patients with Refractory Partial Onset Seizures
11:30 AM - 02:30 PM Abstract 096 - Worsening of Generalized Epilepsy with the Anti-Epileptic Drug Oxcarbazepine
11:30 AM - 02:30 PM Abstract 097 - Lacosamide: Efficacy and Safety as Oral Adjunctive Treatment for Partial-Onset Seizures
11:30 AM - 02:30 PM Abstract 098 - Co-Morbidities and Co-Medication Use in Epilepsy Patients Receiving Antiepileptic Treatment in a Managed Care Setting
11:30 AM - 02:30 PM Abstract 099 - In-Hospital Mortality and Complications of Hemispherectomy: Analysis of a Nationwide Sample
11:30 AM - 02:30 PM Abstract 100 - What Does a Seizure Sound like? The Diagnostic Utility of the Epileptic Cry
11:30 AM - 02:30 PM Abstract 101 - Intravenous Levetiracetam in Children: A Prospective, Safety Study
11:30 AM - 02:30 PM Abstract 102 - Effects of Once-Daily Lamotrigine Extended-Release as Adjunctive Therapy in Patients with Primary Generalized Tonic-Clonic Seizures
11:30 AM - 02:30 PM Abstract 103 - One Year of Clinical Experience with Intravenous Levetiracetam in an Academic Medical Center
11:30 AM - 02:30 PM Abstract 104 - Evaluation of Pregabalin for Maintaining Seizure Freedom in Patients with Partial-Onset Epilepsy: Pooled Analysis of Six Long-Term, Open-Label Clinical Trials
11:30 AM - 02:30 PM Abstract 105 - New Onset Seizure in Elderly: Clinical, Radiological and EEG Characteristics
11:30 AM - 02:30 PM Abstract 106 - Efficacy of Pregabalin Treatment in Patients with Partial-Onset Epilepsy: Pooled Analysis of Six Long-Term, Open-Label Clinical Trials
11:30 AM - 02:30 PM Abstract 107 - Effect of Comorbid Somnolence and Depression on Quality of Life in Persons with Epilepsy
11:30 AM - 02:30 PM Abstract 108 - Vitamin D and Calcium Supplementation and Occurrence of Bone Fractures in Patients with Epilepsy
11:30 AM - 02:30 PM Abstract 109 - Long-Term Follow-Up Results with Vagus Nerve Stimulation in Children with Drug Resistant Epilepsy
11:30 AM - 02:30 PM Abstract 110 - Phenytoin Worsens Balance in Older People with Epilepsy
11:30 AM - 02:30 PM Abstract 111 - Safety and Tolerability of Add-On IV Levetiracetam in Status Epilepticus: A Feasibility Study
11:30 AM - 02:30 PM Abstract 112 - Pharmacological Profile of Perampanel: A Novel, Non-Competitive Selective AMPA Receptor Antagonist
11:30 AM - 02:30 PM Abstract 113 - Anticonvulsant Activity of Perampanel, a Selective AMPA Receptor Antagonist, in Rodent Models of Epileptic Seizure
11:30 AM - 02:30 PM Abstract 114 - False Positive Phencyclidine (PCP) Results in Patients Taking Lamotrigine
11:30 AM - 02:30 PM Abstract 115 - Double-Blind Randomized Controlled Trial of SNT-MC17/Idebenone in Duchenne Muscular Dystrophy
11:30 AM - 02:30 PM Abstract 116 - How Frequently Are Corticosteroids Used in Boys with Dystrophinopathy in the USA: Data from the MDSTARnet
11:30 AM - 02:30 PM Abstract 117 - Immediate Release Oral Pentoxifylline Is Poorly Tolerated in Duchenne Muscular Dystrophy Boys
11:30 AM - 02:30 PM Abstract 118 - Pentoxifylline Treatment Fails To Rescue Muscle Strength and Function Deterioration in Prednisone-Treated Duchenne Muscular Dystrophy
11:30 AM - 02:30 PM Abstract 119 - Defining Treatment Outcomes for the Cardiomyopathy of Dystrophin-Deficiency
11:30 AM - 02:30 PM Abstract 120 - SNT-MC17/Idebenone for the Treatment of Patients with Friedreich's Ataxia: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Efficacy and Safety
11:30 AM - 02:30 PM Abstract 121 - Effects of One Year Enzyme Replacement Therapy in Severe Form of Late Onset Pompe Disease. Severe Late Onset Treatment Study (French SLOTS)
11:30 AM - 02:30 PM Abstract 122 - Molecular Pathology and Response to Enzyme Replacement Therapy in Late-Onset Phenotypes of Acid Maltase Deficiency (AMD)
11:30 AM - 02:30 PM Abstract 123 - Aggressive Immunotherapy Is Successful in Treating Sporadic Late Onset Nemaline Myopathy (SLONM)
11:30 AM - 02:30 PM Abstract 124 - Safety of Intravenous Immune Globulin (IVIG) in the Home Setting in Patients with Autoimmune Neuromuscular Disorders
11:30 AM - 02:30 PM Abstract 125 - Long-Term Immunosuppressive Treatment for Myasthenia Gravis: An 11-Year Experience
11:30 AM - 02:30 PM Abstract 126 - Clinical and Laboratory Differences among Three Types of Generalized Myasthenia Gravis
11:30 AM - 02:30 PM Abstract 127 - Thymectomy in Juvenile Autoimmune Myasthenia Gravis
11:30 AM - 02:30 PM Abstract 128 - A New Immune Reconstitution Inflammatory Syndrome (IRIS): Myasthenia Gravis (MG) with Antibodies Against MuSK in an HIV-Infected Patient
11:30 AM - 02:30 PM Abstract 129 - Neuromuscular Junction Dysfunction in Diabetic Neuropathy
11:30 AM - 02:30 PM Abstract 130 - Paraneoplastic Stiff Person Syndrome (SPS) in Patients with Anti-GAD Antibodies: Report of 2 Cases with SPS-Specific Antigens in Their Tumors
11:30 AM - 02:30 PM Abstract 131 - A Necrotizing Myopathy Associated with Statin Use Is Responsive to Immunomodulatory Agents
11:30 AM - 02:30 PM Abstract 132 - Paraspinal Muscle Biopsies: A Clinical and Electromyographic Study
11:30 AM - 02:30 PM Abstract 133 - Sleep-Disordered Breathing in Oculopharyngeal Muscular Dystrophy: A Clinical and Polysomnography Study
11:30 AM - 02:30 PM Abstract 134 - The Efficacy of BG00012 in Patients with Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses from the Phase 2b Study
11:30 AM - 02:30 PM Abstract 135 - A Short-Term MRI Study Comparing High-Dose Oral Versus Intravenous Methylprednisolone in MS Relapses
11:30 AM - 02:30 PM Abstract 136 - Site Performance in an Investigator-Run Multiple Sclerosis Clinical Trial
11:30 AM - 02:30 PM Abstract 137 - Autologous Attenuated T Cell Vaccine (Tovaxin[reg]) Dose Escalation in Multiple Sclerosis Relapse-Remitting and Secondary Progressive Patients Nonresponsive to Approved Immunomodulatory Therapies
11:30 AM - 02:30 PM Abstract 138 - Is Brain Atrophy Progression in RR-MS Slowed by the Association of Atorvastatin and Interferon Beta-1a? Preliminary Results from an Open-Label, Randomized, Clinical Study
11:30 AM - 02:30 PM Abstract 139 - Interferon Beta-1a and Atorvastatin Combination Therapy: 12-Month Results from an Open-Label, Randomized, Clinical Study
11:30 AM - 02:30 PM Abstract 140 - Relation between MRI and Therapeutic Plasma Exchange (PLEX) Response in Patients with Fulminant CNS Inflammatory Demyelinating Disorders (IDD)
11:30 AM - 02:30 PM Abstract 141 - Effect of Infertility Treatment on Multiple Sclerosis: Report of 4 Cases
11:30 AM - 02:30 PM Abstract 142 - The Interferon Beta-1b 16-Year Long-Term Follow-Up Study: Predictive Clinical and Magnetic Resonance Imaging Markers
11:30 AM - 02:30 PM Abstract 143 - The Effect of Parenteral Cladribine on Relapses and Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: Results of a 2-Year, Double-Blind, Placebo-Controlled, Crossover Study
11:30 AM - 02:30 PM Abstract 144 - Safety and Tolerability of the First Single-Use, Fully Integrated Autoinjector for IM Interferon Beta-1a
11:30 AM - 02:30 PM Abstract 145 - High-Dose Atorvastatin Alone or in Combination with Interferon-beta (IFN-beta) in the Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS)
11:30 AM - 02:30 PM Abstract 146 - Short-Term Effects of Medicinal Cannabis on Spasticity in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 147 - Effects of Subcutaneous Interferon Beta on Disease Parameters and Cognition in Patients with Early Relapsing-Remitting Multiple Sclerosis: Longitudinal Clinical and Cognitive Results from the COGIMUS (COGnition Impairment in MUltiple Sclerosis) Study
11:30 AM - 02:30 PM Abstract 148 - Neutralizing Antibodies Did Not Affect Efficacy of Interferon beta-1b: Further Analysis of the Betaseron[reg] in Newly Emerging Multiple Sclerosis for Initial Treatment Study (BENEFIT)
11:30 AM - 02:30 PM Abstract 149 - A Pilot Trial of Low Dose Naltrexone in Primary Progressive Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 150 - The CARE-MSSM II Trial (Comparison of Alemtuzumab and Rebif[reg] Efficacy in Multiple Sclerosis): Design of a Phase 3, Open-Label, Rater and Dose-Blinded Study of Alemtuzumab in Patients with MS Who Have Relapsed on Therapy
11:30 AM - 02:30 PM Abstract 151 - A Single Center, Randomized, Placebo-Controlled, Double-Crossover Study of the Effects of Low Dose Naltrexone on Multiple Sclerosis Quality of Life
11:30 AM - 02:30 PM Abstract 152 - The Real Life Impact of Early Versus Delayed Treatment of Interferon beta on Long-Term Disability Progression in Relapsing-Remitting Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 153 - Treatment Effect of IFN-beta Is Restored after Disappearance of Neutralizing Antibodies
11:30 AM - 02:30 PM Abstract 154 - Detection of JC/BK Virus in Patients with Multiple Sclerosis Treated with Natalizumab
11:30 AM - 02:30 PM Abstract 155 - The Changing Face of Multiple Sclerosis Clinical Trial Populations: Implications for Ongoing and Future Clinical Studies
11:30 AM - 02:30 PM Abstract 156 - Natalizumab Increases the Proportion of Patients Free of Clinical or MRI Disease Activity in Relapsing Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 157 - Efficacy and Safety of Natalizumab as Escalation Therapy in Relapsing-Remitting Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 158 - Mycophenolate Mofetil in the Treatment of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 159 - Repetitive Transcranial Magnetic Stimulation Can Improve Walking in Multiple Sclerosis Patients with Spastic Paraparesis
11:30 AM - 02:30 PM Abstract 160 - The Efficacy of Cladribine in Relapsing-Remitting Multiple Sclerosis: Clinical Data from a Randomized, Double-Blind, Placebo-Controlled, 18-Month, Phase II Trial
11:30 AM - 02:30 PM Abstract 161 - Impression of Clinical Worsening Fails To Predict Interferon-beta Neutralizing Antibody Status
11:30 AM - 02:30 PM Abstract 162 - Autologous Hematopoetic Stem Cell Transplantation Following High-Dose Immunosuppressive Therapy in Multiple Sclerosis: Six-Year Results
11:30 AM - 02:30 PM Abstract 163 - Does an Innovative Automated Recruitment Process Generate an Unbiased Study Sample from a Pool of Eligible Patients?
11:30 AM - 02:30 PM Abstract 164 - Glatiramer Acetate after Induction with Mitoxantrone in Secondary Progressive Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 165 - How To Prevent Conversion from Clinically Isolated Syndromes to Clinically Defined Multiple Sclerosis? A Cochrane Meta-Analysis of Published Trials
11:30 AM - 02:30 PM Abstract 166 - Short and Long-Term Clinical Efficacy and Safety Outcomes for Multiple Sclerosis (MS) Patients Receiving Mitoxantrone Therapy in Western New York Outpatient Clinical Care Settings
11:30 AM - 02:30 PM Abstract 167 - High Doses Immunosuppression Anteceded by Rescue of Hematopoietic Stem Cells and Followed by Its Intravenous Infusion
11:30 AM - 02:30 PM Abstract 168 - The Effect of Levetiracetam on Cerebellar Intention Tremor in Patients with Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 169 - Diagnosis Criteria and MRI at Baseline in CombiRx - A Preliminary Analysis
11:30 AM - 02:30 PM Abstract 170 - Low-Dose Mitoxantrone as Add-On Therapy in Multiple Sclerosis Unresponsive to Interferon-beta
11:30 AM - 02:30 PM Abstract 171 - The CARE-MSSM I Trial (Comparison of Alemtuzumab and Rebif[reg] Efficacy in Multiple Sclerosis): Design of a Phase 3, Open-Label, Rater-Blinded Study of Alemtuzumab in Treatment-Na[iuml]ve Patients with Relapsing MS
11:30 AM - 02:30 PM Abstract 172 - Successful Treatment of Pyoderma Gangrenosum with a TNF[alpha] Blocker in a Subject with Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 173 - Improvement in Multiple Sclerosis-Related Demyelinating Peripheral Neuropathy Following Aggressive Mitoxantrone Therapy
11:30 AM - 02:30 PM Abstract 174 - Medical Reasons for Dose Adjustment and/or Discontinuation of Mitoxantrone in Clinical Practice
11:30 AM - 02:30 PM Abstract 175 - A Randomized, Open-Label, Parallel-Group, Multicenter Study To Determine the Safety and Efficacy of Mycophenolate Mofetil (Cellcept[reg]) in Mono- and Combination-Therapy with Interferon beta-1a (Avonex[reg]), in Patients with Relapsing-Remitting Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 176 - Glatiramer Acetate (GA) Is Effective in Neutralizing Antibodies to IFNb Positive (NAb+ve) Multiple Sclerosis (MS) Patients
11:30 AM - 02:30 PM Abstract 177 - Effects of Mitoxantrone Treatment on Cognitive and Physical Disability in Patients with Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 178 - Multiple Sclerosis Related Fatigue Improves after Treatment Initiation with Natalizumab
11:30 AM - 02:30 PM Abstract 179 - Phase II Clinical Trial (Halt MS: Immune Tolerance Network) of High Dose Immunosuppressive Therapy (HDIT) and Autologous Hematopoetic Stem Cell Transplantation (AHSCT) for Active Relapsing-Remitting (RR) Multiple Sclerosis (MS): Early Results
11:30 AM - 02:30 PM Abstract 180 - A Combined Analysis of Data from Four Randomized, Double-Blind, Placebo-Controlled Trials of Parenteral Cladribine and One Open-Label Pilot Study To Assess the Safety and Tolerability Profile of Repeated Periods of Cladribine Treatment in Patients with Progressive or Relapsing Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 181 - Effects of Postmenopausal Hormone Therapy on Regional Brain Volumes in Older Women: The Women's Health Initiative Magnetic Resonance Imaging Study (WHIMS-MRI)
11:30 AM - 02:30 PM Abstract 182 - Memantine Augments the Effects of Cholinesterase Inhibition in the Treatment of Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 183 - High Antioxidant Micronutrient Status Increases Cognitive Function in Healthy Subjects
11:30 AM - 02:30 PM Abstract 184 - Discontinuation of Memantine Therapy in Nursing Home Residents with Alzheimer's Disease Is Associated with Increased Utilization of Psychotropic Medications and Decreased Body Weight
11:30 AM - 02:30 PM Abstract 185 - Levetiracetam: Seizure Management for Elderly Patients with Cognitive Impairment
11:30 AM - 02:30 PM Abstract 186 - LX6171: A Novel Potential Treatment for Cognitive Disorders
11:30 AM - 02:30 PM Abstract 187 - 2002-2007 Blueberry Health Study Report: Individual Data Sets Are Now Reaching the 95% Confidence Level
11:30 AM - 02:30 PM Abstract 188 - Measuring Progression of Disease in Frontotemporal Dementia: Therapeutic Trial Implications
11:30 AM - 02:30 PM Abstract 189 - Dimebon Improves Patient Function and Decreases Caregiver Assistance Time in Alzheimer's Disease: One-Year Clinical Trial Results
11:30 AM - 02:30 PM Abstract 190 - Effects of Postmenopausal Hormone Therapy on Volumetric Sub-Clincial Cerebrovascular Disease: The Women's Health Initiative Memory Study - Magnetic Resonance Imaging Study (WHIMS-MRI)
11:30 AM - 02:30 PM Abstract 191 - Mathematical Comparison of a Randomized-Withdrawal Clinical Trial Design and a Parallel-Group Design To Demonstrate Disease Modification in Alzheimer's Disease (AD)
11:30 AM - 02:30 PM Abstract 192 - The Effect of Cholinesterase Inhibitors on the Levels and Activities of Cholinesterases in the Cerebrospinal Fluid of Alzheimer's Disease Patients
11:30 AM - 02:30 PM Abstract 193 - Effects of Memantine on Language and Functional Communication in Patients with Moderate to Severe Alzheimer's Disease Receiving Stable Doses of Donepezil
11:30 AM - 02:30 PM Abstract 194 - Chronic Administration of Melatonin in Drinking Water Decrease Sinaptosomal Rigidity in Senescence-Accelerated Mice
12:00 PM - 01:30 PM Break
Faculty Disclosures
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Robert G. Miller, MD The institution of Dr. Miller has received research support from Nurown.
Joseph I. Sirven, MD, FAAN Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Kapil D. Sethi, MD, FRCP (UK), FAAN Dr. Sethi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine.
Anthony E. Lang, MD, FAAN Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Christopher Goetz, MD, FAAN The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Michael R. Sperling, MD, FAAN Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Patricia K. Coyle, MD, FAAN Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Oksana Suchowersky, MD, FAAN Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Michael Silber, MB, ChB, FAAN Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Mark Hallett, MD, FAAN Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Joseph R. Zunt, MD The institution of Dr. Zunt has received research support from NIH. Dr. Zunt has received publishing royalties from a publication relating to health care.
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Jonathan S. Katz, MD Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calico. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Griffols. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Helen Bronte-Stewart, MD, MSE Dr. Bronte-Stewart has stock in QDG Health. Dr. Bronte-Stewart has received intellectual property interests from a discovery or technology relating to health care.
Paula R. Clemens, MD The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Joseph F. Drazkowski, MD, FAAN Dr. Drazkowski has nothing to disclose.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Charles D. Smith, MD, FAAN No disclosure on file
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
Steven T. DeKosky, MD, FAAN Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. DeKosky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Pharamceuticls. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up-To-Date. Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics .
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Andres M. Kanner, MD, FAAN Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Russell E. Bartt, MD, FAAN Dr. Bartt has nothing to disclose.
Terry D. Fife, MD, FAAN Dr. Fife has nothing to disclose.
Jody Corey-Bloom, MD, PhD, FAAN Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.
Andrew J. Kornberg, MD Dr. Kornberg has nothing to disclose.
George H. Kraft, MD No disclosure on file
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Amer Alshekhlee, MD No disclosure on file
Katherine D. Mathews, MD, FAAN Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Charles S. DeCarli, MD, FAAN Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Subramaniam Sriram, MD Dr. Sriram has nothing to disclose.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Dean M. Wingerchuk, MD, FAAN Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Paul S. Fishman, MD, PhD No disclosure on file
Bashar Katirji, MD, FAAN Dr. Katirji has nothing to disclose.
William H. Theodore, MD, FAAN Dr. Theodore has a non-compensated relationship as a Treasurer and vice president with American Epilepsy Society that is relevant to AAN interests or activities.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Selim R. Benbadis, MD, FAAN Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB.
William J. Weiner, MD No disclosure on file
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Anthony A. Amato, MD, FAAN Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian Therapeutics. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medpace. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care.
David E. Riley, MD Dr. Riley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen.
Frank G. Gilliam, MD, MPH No disclosure on file
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Terence D. Sanger, MD, PhD No disclosure on file
Dennis N. Bourdette, MD, FAAN Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
C. W. Olanow, MD Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
Stanley Fahn, MD, FAAN Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Rodger J. Elble, MD, PhD, FAAN Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage . Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ES Therapeutics. Dr. Elble has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Applied Therapeutics. Dr. Elble has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis.
Martin R. Farlow, MD, FAAN No disclosure on file
Kelly E. Lyons, PhD Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Parkinson's Foundation. Dr. Lyons has a non-compensated relationship as a President with International Essential Tremor Foundation that is relevant to AAN interests or activities.
Emma Ciafaloni, MD, FAAN Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
David H. Miller, MD, MBChB, FRCP No disclosure on file
Ruth H. Whitham, MD, FAAN No disclosure on file
No disclosure on file
Ray L. Watts, MD, FAAN No disclosure on file
Richard A. Rudick, MD, FAAN Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Lisa M. Shulman, MD, FAAN The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Susan T. Iannaccone, MD, FAAN Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. The institution of Dr. Iannaccone has received research support from AveXis. The institution of Dr. Iannaccone has received research support from Biogen. The institution of Dr. Iannaccone has received research support from Sarepta. The institution of Dr. Iannaccone has received research support from PTC Therapeutics. The institution of Dr. Iannaccone has received research support from FibroGen. The institution of Dr. Iannaccone has received research support from ReveraGen. The institution of Dr. Iannaccone has received research support from MDA. The institution of Dr. Iannaccone has received research support from PPMD. The institution of Dr. Iannaccone has received research support from NIH. Dr. Iannaccone has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Corrado Angelini, MD, FAAN Dr. Angelini has nothing to disclose.
John G. Nutt, MD, FAAN No disclosure on file
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Bruno Dubois, MD No disclosure on file
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Stacy A. Rudnicki, MD, FAAN Dr. Rudnicki has received personal compensation for serving as an employee of Cytokinetics. Dr. Rudnicki has stock in Cytokinetics.
Diana M. Escolar, MD, FAAN No disclosure on file
Charles J. Vecht, MD, PhD, FAAN No disclosure on file
Rajesh Pahwa, MD, FAAN Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Andrew D. Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Howard Fillit, MD No disclosure on file
Thomas F. Scott, MD Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Robert T. Leshner, MD, FAAN No disclosure on file
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Gregory Krauss, MD Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Douglas S. Goodin, MD No disclosure on file
Howard Feldman, MD, FAAN The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Brendan J. Kelley, MD, FAAN Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Matthew B. Stern, MD Dr. Stern has received personal compensation for serving as an employee of Mediflix, Inc. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stern has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.
Vicenta Salanova, MD, FAAN No disclosure on file
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Brandy R. Matthews, MD, FAAN No disclosure on file
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Gisele R. Oliveira, MD No disclosure on file
Carl W. Bazil, MD, PhD, FAAN Dr. Bazil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medical Letter . Dr. Bazil has received publishing royalties from a publication relating to health care.
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Paul S. Aisen, MD No disclosure on file
Sally Shumaker, PhD No disclosure on file
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Marcel Hungs, MD, PhD, FAAN No disclosure on file
Katherine H. Noe, MD, PhD, FAAN Dr. Noe has a non-compensated relationship as a committe member, Epilepsy MOC article review pilot with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Jayne R. Wilkinson, MD, MSCE Dr. Wilkinson has nothing to disclose.
H. C. Diener, MD, FAAN Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Sebastian Koch, MD Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.
Majaz Moonis, MD, FAHA, FAAN Dr. Moonis has nothing to disclose.
Kerstin Bettermann, MD, PhD, FANA, FAAN Dr. Bettermann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Anne M. Connolly, MD, FAAN Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. The institution of Dr. Connolly has received research support from Muscular Dystrophy Association. The institution of Dr. Connolly has received research support from NIH.
Robin A. Conwit, MD, FAAN Dr. Conwit has nothing to disclose.
Marinos C. Dalakas, MD, FAAN Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Tanis J. Ferman, PhD Ms. Ferman has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Jorge G. Burneo, MD, MSPH, FAAN Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Orrin Devinsky, MD, FAAN Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Imran I. Ali, MD, FAAN Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Anette E. Schrag, MD Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer ingelheim. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Dr. Schrag has received research support from NIHR, EU, Parkinson's UK, MDS.
Stephanie Scala No disclosure on file
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Simone Appenzeller, PhD No disclosure on file
Li M. Li, MD No disclosure on file
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Jeffrey B. English, MD Dr. English has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biogen idec. Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bristol myer squibb. Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for genentech. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi genzyme. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for biogen idec. Dr. English has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for genzyme. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for genentech. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bristol myer squibb. Dr. English has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therpeutics. Dr. English has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. English has received intellectual property interests from a discovery or technology relating to health care.
Wolf-Ruediger Schabitz, MD No disclosure on file
Anne E. Hammer No disclosure on file
Shoji Hemmi, MD No disclosure on file
Shin J. Oh, MD, FAAN No disclosure on file
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Karen Anderson No disclosure on file
Ann Gruber-Baldini No disclosure on file
Gwendolyn C. Claussen, MD No disclosure on file
Marla B. Morgan, MD Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Julian Benito-Leon No disclosure on file
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Felix Bermejo-Pareja, MD No disclosure on file
Norman Putzki, MD No disclosure on file
Volker Limmroth, MD, PhD No disclosure on file
James E. Galvin, MD, MPH Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Catherine M. Roe, PhD No disclosure on file
Key-Chung Park, MC No disclosure on file
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Harry O. Openshaw, MD No disclosure on file
Keith R. Edwards, MD, FAAN No disclosure on file
Hao Zhang, PhD No disclosure on file
Warren L. Felton III, MD Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Elizabeth Fisher, PhD No disclosure on file
George J. Hutton, MD, FAAN Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Elissaios Karageorgiou, MD, PhD, FAAN Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union. The institution of Dr. Karageorgiou has received research support from Alzheimer's Association.
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Thierry Kuntzer, MD No disclosure on file
Roberto Bergamaschi Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Babak Boroojerdi, MD Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCB Biosciences.
Peter A. LeWitt, MD Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Peter Widdess-Walsh, MD No disclosure on file
Dae H. Lee, MD No disclosure on file
Seong B. Koh, MD No disclosure on file
Christopher Kipps, MD, MBBS No disclosure on file
Liang Lu, MD, FAAN Dr. Lu has nothing to disclose.
Maria P. Amato, PhD Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Martine Vercelletto, MD No disclosure on file
Jaime Kulisevsky, MD, PhD Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Esteve. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia.
Luca Durelli, MD No disclosure on file
Marinella Clerico, MD Dr. Clerico has nothing to disclose.
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Angelo Ghezzi, MD No disclosure on file
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Andrea Falini No disclosure on file
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Steven R. Schwid, MD, FAAN No disclosure on file
Phyllis M. Salzman, PhD No disclosure on file
Christine Tranchant, MD No disclosure on file
Frederic Blanc No disclosure on file
Howard S. Rossman, DO No disclosure on file
Mohamad Koubeissi, MD, FAAN Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Gilles Edan, MD No disclosure on file
James T. Becker, PhD No disclosure on file
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Stuart D. Cook, MD, FAAN No disclosure on file
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Douglas R. Jeffery, MD, PhD No disclosure on file
Paul W. O'Connor, MD No disclosure on file
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Julaine M. Florence Ms. Florence has nothing to disclose.
Gunnar Buyse, MD, PhD No disclosure on file
Nathalie M. Goemans, MD Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Goemans has received publishing royalties from a publication relating to health care.
Erik K. Henricson, MPH No disclosure on file
Peter Berlit, MD, FAAN No disclosure on file
George P. Rice, MD No disclosure on file
Andreas Konieczny No disclosure on file
George C. Ebers, MD No disclosure on file
Abu Nasar No disclosure on file
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Susan L. Perlman, MD Dr. Perlman has nothing to disclose.
Cedric S. Raine, PhD, DSc No disclosure on file
James D. Bowen, MD Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BristolMyers Squibb. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Bowen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bowen has received research support from Biogen IDEC. The institution of Dr. Bowen has received research support from Genentech. The institution of Dr. Bowen has received research support from Genzyme. The institution of Dr. Bowen has received research support from Novartis. The institution of Dr. Bowen has received research support from Roche.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Francisco De Assis Gondim, MD, PhD, MSc, FAAN No disclosure on file
Tanvir Syed, MD No disclosure on file
Ann F. Hsu, PhD, PharmD No disclosure on file
Jonathan L. Carter, MD Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Bruce R. Reed, PhD No disclosure on file
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Rosebud O. Roberts, MD No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH. Dr. Geda has received intellectual property interests from a discovery or technology relating to health care.
Goran Rakocevic, MD, FAAN Dr. Rakocevic has nothing to disclose.
Ging-Yuek R. Hsiung, MD, FAAN Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen.
Claudia Jacova No disclosure on file
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Robert Spinner No disclosure on file
Kimberly Amrami, MD Kimberly Amrami, MD has nothing to disclose.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Robert J. Ivnik, PhD No disclosure on file
Glenn E. Smith, MD, PhD No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Thomas L. Davis, MD Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Parkinson Foundation.
Ludwig Aigner, PhD No disclosure on file
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Jacqueline Palace Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Chris H. Polman, MD No disclosure on file
Frederick E. Munschauer III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
William E. Klunk, MD, PhD No disclosure on file
Ajith Sominanda No disclosure on file
Jan A. Hillert, MD Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Lars Bauer, MD No disclosure on file
Rupert Sandbrink, MD, PhD Dr. Sandbrink has received personal compensation for serving as an employee of Topas Therapeutics. Dr. Sandbrink has received personal compensation for serving as an employee of Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Forward Pharma. Dr. Sandbrink has received stock or an ownership interest from Topas Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Bayer.
Christoph Pohl, MD No disclosure on file
Antonio Bertolotto, MD, FAAN Dr. Bertolotto has nothing to disclose.
Marco Capobianco, MD No disclosure on file
Simona Malucchi No disclosure on file
Alessia Di Sapio, MD No disclosure on file
Francesca Gilli No disclosure on file
Nancy L. Earl, MD No disclosure on file
Ignacio F. Casas-Parera, MD, PhD, FAAN Dr. Casas-Parera has received publishing royalties from a publication relating to health care.
H. M. Gach, PhD MS No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
J. Theodore Phillips, MD, PhD, FAAN No disclosure on file
William H. Stuart, MD, FAAN Dr. Stuart has nothing to disclose.
Christian Confavreux, MD No disclosure on file
Michael A. Panzara, MD, MPH Dr. Panzara has received personal compensation for serving as an employee of Neurvati Neurosciences. Dr. Panzara has received personal compensation for serving as an employee of GRIN Therapeutics. Dr. Panzara has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Wave Life Sciences. Dr. Panzara has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Athira Pharma. Dr. Panzara has stock in GRIN Therapeutics. Dr. Panzara has stock in Cadenza Bio. Dr. Panzara has stock in Athira Pharma. Dr. Panzara has stock in Wave Life Sciences. Dr. Panzara has stock in Sanofi.
Michele K. York, PhD, ABPP-CN Dr. York has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RAD-PD. The institution of Dr. York has received research support from Michael J. Fox Foundation. The institution of Dr. York has received research support from NIH. The institution of Dr. York has received research support from Takeda.
Vera Novak, MD No disclosure on file
Gustavo Ortiz, MD No disclosure on file
Kinya Ishikawa, MD, PhD Dr. Ishikawa has nothing to disclose.
Hidehiro Mizusawa, MD, PhD No disclosure on file
Taiji Tsunemi, MD, PhD No disclosure on file
Wolfgang Grisold, MD, FAAN No disclosure on file
Luci Blasucci, RN No disclosure on file
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Bradley Erickson No disclosure on file
Minas Tzagournissakis, MD No disclosure on file
Andreas J. Plaitakis, MD No disclosure on file
Anthony Reder, MD Dr. Reder has nothing to disclose.
Giuseppe Zappala, MD No disclosure on file
Kun W. Park, MD, PhD No disclosure on file
Marlis Frey, APN No disclosure on file
Peter Chang No disclosure on file
Richard K. Kim, MD Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Olivier Rascol, MD, PhD Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Gina Remington No disclosure on file
Stephen Weigand Stephen Weigand has nothing to disclose.
Diane L. Cookfair, PhD MS No disclosure on file
Victor Biton, MD Dr. Biton has nothing to disclose.
Susan Kerls No disclosure on file
Alain Vuong No disclosure on file
John A. Messenheimer, Jr., MD Dr. Messenheimer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zynerba Pharmaceuticals. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care. Dr. Messenheimer has received intellectual property interests from a discovery or technology relating to health care.
Stefano Bastianello No disclosure on file
Jonathan P. Hosey, MD, FAAN Dr. Hosey has nothing to disclose.
Per Solberg Sorensen, MD, PhD, FAAN Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Dan M. Mungas, PhD Dr. Mungas has nothing to disclose.
Andrew J. Lees, MD, FRCP Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Britannia. Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Bial Pharma.
Marcia F. Rupnow, PhD No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FAAN Dr. Nascimento has nothing to disclose.
Marcos R. De Freitas, MD, PhD No disclosure on file
Basil Sharrack, MD, PhD, FAAN Dr. Sharrack has nothing to disclose.
Michael Tocco No disclosure on file
Pierre Tariot Pierre Tariot has received personal compensation for serving as an employee of Banner Alzheimer's Institute. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WebMD. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcadia. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioXcel. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNOVA. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Pierre Tariot has received intellectual property interests from a discovery or technology relating to health care.
Maria Tintore-Subirana, MD No disclosure on file
Robert W. Shields, Jr., MD, FAAN Dr. Shields has nothing to disclose.
E Malca Resnick, PhD No disclosure on file
Bernard M. Uitdehaag, MD, PhD, FAAN Dr. Uitdehaag has nothing to disclose.
Daniel D. Mikol, MD, PhD Dr. Mikol has received personal compensation for serving as an employee of NervGen. Dr. Mikol has received personal compensation for serving as an employee of Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for NervGen. Dr. Mikol has stock in NervGen. Dr. Mikol has stock in Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NervGen.
Carlo Pozzilli Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Suzanne Hendrix, PhD Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Constantine Lyketsos Constantine Lyketsos has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Avanir, Karuna, Maplight, Axsome, GW Research Limited, Merck, EXCIVA GmbH, Otsuka, IntraCellular Therapies, Medesis, BMS, IQVIA. Constantine Lyketsos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. The institution of Constantine Lyketsos has received research support from NIA. Constantine Lyketsos has received publishing royalties from a publication relating to health care. Constantine Lyketsos has received publishing royalties from a publication relating to health care.
Deanna Saylor, MD, MHS, FAAN Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from American Academy of Neurology. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
A. D. Rothner, MD No disclosure on file
Nancy L. Kuntz, MD, FAAN Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Roger L. Albin, MD Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex. The institution of Dr. Albin has received research support from NIH-NINDS. The institution of Dr. Albin has received research support from Parkinson's Foundation. The institution of Dr. Albin has received research support from Michael J. Fox Foundation. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as a Grant Application Reivewer with Michael J. Fox Foundation.
Robert G. Holloway, MD, MPH, FAAN Dr. Holloway has nothing to disclose.
Deborah M. Miller, PhD Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Akihisa Mori, PhD Mr. Mori has received personal compensation for serving as an employee of SNLD, Ltd., Japan.
Jeannette A. Barrett, PhD No disclosure on file
Mark Keegan, MD, FAAN Dr. Keegan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Keegan has received publishing royalties from a publication relating to health care. Dr. Keegan has received publishing royalties from a publication relating to health care.
Farrukh S. Khan, MD, MBBS No disclosure on file
Lauren Seeberger, MD, FAAN Dr. Seeberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocine Biosciences. Dr. Seeberger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Seeberger has received research support from Neurocrine. The institution of Dr. Seeberger has received research support from TEVA.
Patricio S. Espinosa, MD, MPH, FAAN Dr. Espinosa has nothing to disclose.
Jayashri Srinivasan, MD, PhD, MRCP, FAAN Dr. Srinivasan has nothing to disclose.
Allan D. Wu, MD, FAAN Dr. Wu has a non-compensated relationship as a Neuroscience Steering Board with Epic that is relevant to AAN interests or activities. Dr. Wu has a non-compensated relationship as a Subject Matter Expert Panel with Michael J Fox Foundation that is relevant to AAN interests or activities. Dr. Wu has a non-compensated relationship as a Advisory Committee with Parkinson Foundation that is relevant to AAN interests or activities. Dr. Wu has a non-compensated relationship as a Advisory Board with Brain and Life that is relevant to AAN interests or activities. An immediate family member of Dr. Wu has a non-compensated relationship as a Board Member with Illinois State Neurologic Society that is relevant to AAN interests or activities.
Aaron Ellenbogen, DO Dr. Ellenbogen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for allergan. Dr. Ellenbogen has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for allergan. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Frauke Zipp, MD Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. The institution of Dr. Zipp has received research support from BMBF. The institution of Dr. Zipp has received research support from DFG. The institution of Dr. Zipp has received research support from PMSA. The institution of Dr. Zipp has received research support from Sanofi Genzyme. The institution of Dr. Zipp has received research support from UCB. The institution of Dr. Zipp has received research support from Eisai. The institution of Dr. Zipp has received research support from SK Life Science. The institution of Dr. Zipp has received research support from Abbott. The institution of Dr. Zipp has received research support from Actelion. The institution of Dr. Zipp has received research support from Bayer. The institution of Dr. Zipp has received research support from Servier. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Novartis. Dr. Zipp has received personal compensation in the range of $0-$499 for serving as a Reviewer with Universite de Geneve. Dr. Zipp has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Oppenheim Förderpreis für Multiple Sklerose. Dr. Zipp has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with EKFS. Dr. Zipp has a non-compensated relationship as a Associate Editor with Brain that is relevant to AAN interests or activities. Dr. Zipp has a non-compensated relationship as a Advisor with Science Translational Medicine that is relevant to AAN interests or activities.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Tobias Loddenkemper, MD, FAAN No disclosure on file
Frederick A. Schmitt, PhD The institution of Dr. Schmitt has received research support from NIH.
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Adriana J. Carra, MD No disclosure on file
Nicolaas I. Bohnen, MD, PhD, FAAN Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
Christopher Skidmore, MD Dr. Skidmore has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SALTZ MONGELUZZI BENDESKY LLC. The institution of Dr. Skidmore has received research support from Neuropace. The institution of Dr. Skidmore has received research support from Jazz Pharmaceuticals. The institution of Dr. Skidmore has received research support from Rapport Therapeutics.
Scott Mintzer, MD No disclosure on file
Glenda Lacerda, MD Dr. Lacerda has nothing to disclose.
Sigmund G. Jenssen, MD No disclosure on file
Sun U. Kwon, MD No disclosure on file
Dong-wha Kang, MD No disclosure on file
H. R. Jones, Jr., MD No disclosure on file
Gabriel R. De Freitas, MD, PhD Dr. De Freitas has nothing to disclose.
Alida F. Griffith, MD No disclosure on file
Seyed M. Mirsattari, MD, PhD, FRCPC Dr. Mirsattari has nothing to disclose.
William A. Sheremata, MD No disclosure on file
Ejaz Shamim, MD, MS, MBA, FAAN The institution of Dr. Shamim has received research support from Michael J. Fox Foundation.
Ruxandra M. Costa, MD No disclosure on file
Thorsten Eickenhorst, MD No disclosure on file
Kelly D. Flemming, MD Dr. Flemming has nothing to disclose.
Vanessa K. Hinson, MD, PhD, FAAN The institution of Dr. Hinson has received research support from Biogen. The institution of Dr. Hinson has received research support from Scion Neurostim. The institution of Dr. Hinson has received research support from PPD Development/Takeda Development. The institution of Dr. Hinson has received research support from Parexel Biopharma. The institution of Dr. Hinson has received research support from Impax Laboratories.
Maromi Nei, MD No disclosure on file
Sasha Zivkovic, MD, FAAN Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical services.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Daniel Costello, MD Dr. Costello has nothing to disclose.
Brian N. Maddux, MD, PhD No disclosure on file
Faisal M. Raja, MD No disclosure on file
Navneet Kumar, MD, MBBS No disclosure on file
Kalarickal Oommen, MD, FAAN No disclosure on file
Robert Beach, MD, PhD, FAAN The institution of Dr. Beach has received research support from Neurona.
Jennifer L. Cox, PhD Dr. Cox has nothing to disclose.
Andro Zangaladze, MD, PhD, FAAN No disclosure on file
Carol F. Lippa, MD Dr. Lippa has nothing to disclose.
Mary Sano, PhD Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Avenir. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for BioXcel. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for CogRx. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for F. Hoffman LaRoche. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Minerva Neuroscience. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoNordisk. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for Pfizer. Dr. Sano has received personal compensation in the range of $0-$499 for serving as a Consultant for vTv Therapeutics. Dr. Sano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's Association. Dr. Sano has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Psychogeriatric Association.
Edward Fox, MD, PhD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Luis A. Chui, MD No disclosure on file
Minhua Yang No disclosure on file
Tulio E. Bertorini, MD Dr. Bertorini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Bertorini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Bertorini has received publishing royalties from a publication relating to health care.
Stephen M. Graham, PhD No disclosure on file
Gustavo Alva, MD Dr. Alva has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Alva has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for neurocrine. The institution of Dr. Alva has received research support from Neurocrine.
Steve Chung, MD, FAAN The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Shree Pandya, DPT No disclosure on file
David A. Wolk, MD, FAAN Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care.
Amy Pace, ScD No disclosure on file
Kara Chisholm, MD No disclosure on file
P. D. Charles, MD, FAAN Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Upinder K. Dhand, MD, FAAN No disclosure on file
Alberto Rodriguez Alfici, MD No disclosure on file
Maria Trojano Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Steven A. Greenberg, MD Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abcuro, Inc.. Dr. Greenberg has stock in Abcuro. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care.
Elena Salvatore, MD No disclosure on file
Robert Hyde, PhD Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Reina Benabou, MD, PhD No disclosure on file
Pascal Laforet No disclosure on file
Ed Whalen Ed Whalen has received personal compensation for serving as an employee of Pfizer. Ed Whalen has stock in Pfizer.
Jill B. Conner, PhD, MS No disclosure on file
Latha Ganti, MD, MS, MBA, FACEP Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Eric Edgar, MD No disclosure on file
Alberto L. Dubrovsky, MD No disclosure on file
Timothy M. Miller, MD No disclosure on file
Ismael Ramadan Ali No disclosure on file
J R. McCarten, MD No disclosure on file
Jukya T. Peltola No disclosure on file
Davide Maimone, MD, PhD Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva.
Sotirios A. Parashos, MD, PhD Dr. Parashos has received stock or an ownership interest from Abbott. Dr. Parashos has received research support from Park Nicollet Health Services. Dr. Parashos has received publishing royalties from a publication relating to health care.
David R. Lynch, MD, PhD The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Giuseppe Salemi, MD No disclosure on file
Anne-Marie Ergis No disclosure on file
Nina Barisic, MD, PhD The institution of Dr. Barisic has received personal compensation in the range of $0-$499 for serving as a Consultant for roche. The institution of Dr. Barisic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Ashraf M. Abdou, MD Dr. Abdou has nothing to disclose.
Gilmore N. O'Neill, MD, MB, MRCPI No disclosure on file
Katherine T. Dawson, MD No disclosure on file
Anne M. Murray, MD No disclosure on file
Maria R. Tola, MD No disclosure on file
Catherine L. Wielinski, MPH No disclosure on file
Nils Koch-Henriksen, MD Dr. Koch-Henriksen has nothing to disclose.
Peter Novak, MD Dr. Novak has received personal compensation for serving as an employee of Dysimmune Disease Foundation. Dr. Novak has stock in Pfeizer. Dr. Novak has stock in Moderna. Dr. Novak has stock in Novavax. Dr. Novak has stock in Editas Medicine. Dr. Novak has stock in Prothena. Dr. Novak has received publishing royalties from a publication relating to health care.
Allesandra Oggero No disclosure on file
Klaus Schmierer, MD, PhD Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Paolo Livrea No disclosure on file
Claudio G. Mazia, MD No disclosure on file
Yu-Tze Ng, MD, FRACP, FAAN No disclosure on file
Robert A. Sweet Robert A. Sweet has nothing to disclose.
Amilton A. Barreira, MD No disclosure on file
Mefkure Eraksoy, MD Dr. Eraksoy has nothing to disclose.
Antonio Carota, MD No disclosure on file
Andres M. Villa, MD Dr. Villa has nothing to disclose.
Damiano Paolicelli Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Christian Grommes, MD Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BTG. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grommes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curis. Dr. Grommes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono.
Edward Kim, MD Dr. Kim has nothing to disclose.
Seung Hun Oh, MD No disclosure on file
Siddharama Pawate, MD The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Lakshmi N. Ranganathan, MD, PhD, FAAN Dr. Ranganathan has nothing to disclose.
Suparna R. Krishnaiengar, MD Dr. Krishnaiengar has nothing to disclose.
Ivan Rektor No disclosure on file
Bettina M. Cockroft, MD, MBA No disclosure on file
Suzanne Reichwein, BASW No disclosure on file
Aurora Fuiani, MD No disclosure on file
Paola Cavalla No disclosure on file
G. P. Gliebus, MD, FAAN Dr. Gliebus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai.
Gonzalo Revuelta, DO The institution of Dr. Revuelta has received research support from NIH.
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Pedro Bermejo, MD No disclosure on file
Asit Tripathy, MD No disclosure on file
M. Fernanda Bellolio, MD No disclosure on file
Claire Boutoleau-Bretonniere, MD No disclosure on file
Kandan Kulandaivel, MD No disclosure on file
Jim C. Williams, PhD No disclosure on file
Cordelia Erickson-Davis No disclosure on file
Mark Espeland, PhD The institution of Dr. Espeland has received research support from Alzheimer's Association. The institution of Dr. Espeland has received research support from National Institutes of Health. Dr. Espeland has received personal compensation in the range of $500-$4,999 for serving as a Consultant with National Institutes of Health.
Jackie Durfee No disclosure on file
Sailaja Enduri, MD No disclosure on file
JaNean Engelstad JaNean Engelstad has nothing to disclose.
Domingo O. Garcea, MD No disclosure on file
Maira Gironi No disclosure on file
David Irwin, MD The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Anu Jacob, MD Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION.
Bong Hui Kang No disclosure on file
Mai Yamakawa, MD Dr. Yamakawa has nothing to disclose.
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Fabio Pellegrini Fabio Pellegrini has received personal compensation for serving as an employee of Biogen. Fabio Pellegrini has received stock or an ownership interest from Biogen.
Nils Peters No disclosure on file
Michael Potchen No disclosure on file
Mathew J. Pulicken, MD, MHS Dr. Pulicken has nothing to disclose.
Niranjan Rao No disclosure on file
Thomas Meier, PhD No disclosure on file
Wilson Marques, Jr., MD Dr. Marques has nothing to disclose.
Jee Hoon Roh, MD, PhD No disclosure on file
Andrea L. Rosso, MPH No disclosure on file
Patricio H. Espinosa Del Pozo, MD No disclosure on file
John Ratchford, MD Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Karen Cheng, MD No disclosure on file
G. B. Young, MD, FAAN No disclosure on file
Ronald Wilson, MD No disclosure on file
Philip M. Brown, MD No disclosure on file
Deepa E. Nidhiry, MD No disclosure on file
Erich Schmutzhard No disclosure on file
David E. Friedman, MD No disclosure on file
Joseph S. Kass, MD, JD, FAAN Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Girish K. Hiremath No disclosure on file
Carmen Terron Cuadrada No disclosure on file
Mauro Zaffaroni No disclosure on file
Rajiv Padmanabhan, MD Dr. Padmanabhan has nothing to disclose.
Mohammad Alsharabati, MD No disclosure on file
Lucia Moiola, MD, PhD Dr. Moiola has nothing to disclose.
Juliana Bronzova No disclosure on file
William D. Honeycutt, MD Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Honeycutt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Honeycutt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Honeycutt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Honeycutt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celegene.
Scott J. Hunter, PhD No disclosure on file
Catherine Griffin, MD No disclosure on file
Anjali N. Shah, MD No disclosure on file
Kohilavani Velayudam, MD No disclosure on file
Haichen Yang, MD No disclosure on file
Gina Eagle, MD No disclosure on file
Karola Beckmann No disclosure on file
Uros Rot, DO No disclosure on file
Ziad Haddad, MD No disclosure on file
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Brian D. Loftus, MD The institution of Dr. Loftus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Loftus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Loftus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Loftus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel. The institution of Dr. Loftus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioscience Delivery. The institution of Dr. Loftus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Loftus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Loftus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Loftus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. The institution of Dr. Loftus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Loftus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Loftus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. The institution of Dr. Loftus has received research support from Foundation for a Better QOL.
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Steven Chao, MD, PhD No disclosure on file
L J. Greenfield, Jr., MD, PhD, FAAN Dr. Greenfield has received publishing royalties from a publication relating to health care.
Nabeel Herial, MD, MPH, FAAN Dr. Herial has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic.
David Orlikowski, MD Dr. Orlikowski has nothing to disclose.
Peter R. Kinkel, MD No disclosure on file
Judith L. Heidebrink, MD The institution of Dr. Heidebrink has received research support from Eli Lilly. The institution of Dr. Heidebrink has received research support from Eisai. The institution of Dr. Heidebrink has received research support from NIH. The institution of Dr. Heidebrink has received research support from Alzheimer's Association. The institution of Dr. Heidebrink has received research support from Cognition Therapeutics. Dr. Heidebrink has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member for the IMPACT-AD Clinical Trials course with the University of Southern California (funded by NIA/Alzheimer's Association).
Kimberly A. Cole, PhD, NP Ms. Cole has nothing to disclose.
Flavia Nelson, MD Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Brent P. Goodman, MD Dr. Goodman has nothing to disclose.
Sheng-Han Kuo, MD, FAAN Dr. Kuo has nothing to disclose.
Jean K. Mah, MD, FRCPC, FAAN Dr. Mah has nothing to disclose.
Jennifer R. Molano, MD, FAAN Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Omar Ayoub, MBBS No disclosure on file
Ksenija Gorni Dr. Gorni has received personal compensation for serving as an employee of Hoffman La Roche.
Yoram Nevo, MD No disclosure on file
David A. Krendel, MD, FAAN No disclosure on file
Phyllis Grable-Esposito, MD No disclosure on file
Lori L. Billinghurst, MD Dr. Billinghurst has nothing to disclose.
James Jordan, MD, FAAN Dr. Jordan has nothing to disclose.
Hoda Elzawahry, MD Dr. Elzawahry has nothing to disclose.
Aarti Sarwal, MD, FAAN Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Soraya P. Da Silva, MD No disclosure on file
Abdullahi Ibrahim, FAAN No disclosure on file
Yakub W. Nyandaiti, MBBS No disclosure on file
Sunday A. Bwala, MD No disclosure on file
Shakti K. Agrawal No disclosure on file
Shouwen Zhang, MD No disclosure on file
Annette Wundes, MD, FAAN The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Karen Fisher No disclosure on file
Phil Nichols, MD No disclosure on file
Catherine A. Belin, MD No disclosure on file
Antoine F. Carpentier No disclosure on file
Zbigniew Stelmasiak, PhD No disclosure on file
Do-Young Kwon No disclosure on file
Maria Isabel Arrigoni, MD No disclosure on file
Miguel G. Copello, MD No disclosure on file
Jose Maria Blasco, PhD No disclosure on file
Derya Kaya No disclosure on file
Heloisa H. Ruocco No disclosure on file
Susan M. Resnick, PhD No disclosure on file
Khurram A. Siddiqui, MBBS, FRCP No disclosure on file
Konner Hamous No disclosure on file
Smitha Suravaram No disclosure on file
Sanjay Mittal, MD Dr. Mittal has nothing to disclose.
Azedeh Beheshtian, MD No disclosure on file
Elena Kornyeyeva, MD No disclosure on file
Tiffany P. Nguyen, MBA, CCRA No disclosure on file
Raimund Helbok No disclosure on file
Gerard Pinol-Ripoll No disclosure on file
Sang-Ahm Lee, MD Dr. Lee has nothing to disclose.
Steven A. Sandstrom, MD No disclosure on file
Jean Baptiste Chanson No disclosure on file
Susan Gailey No disclosure on file
R M. Sadler, MD No disclosure on file
Renaud A. Du Pasquier, MD, FAAN Dr. Du Pasquier has nothing to disclose.
Filippo Martinelli Boneschi No disclosure on file
Claudio Solaro, MD No disclosure on file
Marta Radaelli Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Sebastiano Bucello, MD Dr. Bucello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bucello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Carmen Garcia No disclosure on file
Dee E. Silver, MD No disclosure on file
Laura Coker, PhD No disclosure on file
Jesus Porta No disclosure on file
Dipakkumar P. Pandya, MD, FAAN Dr. Pandya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBIVIE.
Jamie Forlenza No disclosure on file
Ramaratnam Sridharan, MD, FAAN No disclosure on file
Deanne Sykes No disclosure on file
Sarah Z. Lu, MD, PhD No disclosure on file
Marcin P. Mycko, MD No disclosure on file
Sara B. Mitchell, MD Dr. Mitchell has nothing to disclose.
Joris W. Uges No disclosure on file
Pietro Annovazzi No disclosure on file
Federica Esposito Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Mario Quarantelli, MD No disclosure on file
Roberta Lanzillo Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Vincenzo Brescia Morra, MD Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Joseph Giuffrida, PhD No disclosure on file
Takahisa Hanada No disclosure on file
Naoki Tokuhara No disclosure on file
Paolo A. Muraro, MD, PhD No disclosure on file
Carlo Avolio, MD No disclosure on file
Alessandra Lugaresi, MD Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to AAN interests or activities.
Giacomo Lus Giacomo Lus has nothing to disclose.
Emrico Millefiorimi, PhD No disclosure on file
Paolo Rossi No disclosure on file
Marika Vianello No disclosure on file
Mario Halfon No disclosure on file
Vladimiro Sinay, MD No disclosure on file
Dustin A. Heldman, PhD Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Erin Abner No disclosure on file
Roberto M. Velez, MD No disclosure on file
Richard Kryscio No disclosure on file
Araya Puwanant, MD The institution of Dr. Puwanant has received research support from NIH/NINDS.
Pierre Vankan No disclosure on file
Bum Joon Kim Dr. Kim has nothing to disclose.
Paulo Shiroma No disclosure on file
Daniel A. Drubach, MD, FAAN No disclosure on file
Bruno Eymard, MD No disclosure on file
William Knebel No disclosure on file
Stefanie Mueller-Schunk Stefanie Mueller-Schunk has nothing to disclose.
Kyung-Cheon Chung, MD No disclosure on file
Lauren Puccio No disclosure on file
Shirley Chen, DO No disclosure on file
Martijn Muller, PhD No disclosure on file
Mikhail Piradov, MD No disclosure on file
Elena Gnedovskaya No disclosure on file
Julia Ryabinkina No disclosure on file
Michael Rigas, PharmD No disclosure on file
Zahid Cheema, MD, FAAN No disclosure on file
Jung Hwa Kim No disclosure on file
Tae B. Ahn, MD No disclosure on file
Kiyobumi Ota No disclosure on file
Hugh D. Allen No disclosure on file
Devanshi Gupta, MD, FAAN Dr. Gupta has nothing to disclose.
Omar Garcia No disclosure on file
Jun Shimizu, MD, PhD No disclosure on file
Michel Baulac, MD No disclosure on file
Teresa Leon, MD, PhD Dr. Leon has received personal compensation for serving as an employee of Novo Nordisk A/S Copenhagen. Dr. Leon has stock in Novo Nordisk. Dr. Leon has stock in Pharma Mar.
Kenny S. Frazier No disclosure on file
Daniel W. Walke, PhD No disclosure on file
William E. Heydorn, PhD No disclosure on file
Juliana Setyawan, PharmD, MS No disclosure on file
Ana C. Sampaio, MD No disclosure on file
G. Van Scharrenburg No disclosure on file
Aviva S. Bojko, MD No disclosure on file
Eric B. Geller, MD No disclosure on file
Rina F. Goldberg, MD Dr. Goldberg has nothing to disclose.
Mangala A. Nadkarni, MD No disclosure on file
Olga Finlayson, MD No disclosure on file
David C. Diosy, MD Dr. Diosy has nothing to disclose.
Warren T. Blume, MD No disclosure on file
Richard McLachlan, MD No disclosure on file
Stacey Cofield No disclosure on file
Katherine A. James, PhD No disclosure on file
Pawel Grieb No disclosure on file
Adriana M. Strutt, PhD No disclosure on file
Alicia Ford No disclosure on file
Bruno J. Giordani, PhD No disclosure on file
Gabriel Moddel No disclosure on file
Jack C. Sipe, MD, FAAN No disclosure on file
Jason Gardner, PhD No disclosure on file
Stefano Tamburin No disclosure on file
Maria C. Polidori, MD No disclosure on file
Gereon Nelles, MD, PhD, FAAN Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Memodio. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industrial. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for German Neurologists Professional Organization. Dr. Nelles has received publishing royalties from a publication relating to health care.
Michael Eliasziw No disclosure on file
Pauline C. Anderson No disclosure on file
Camila Pupe, MD Dr. Pupe has nothing to disclose.
Hilary Ong No disclosure on file
Jens Wurfel No disclosure on file
Judith Bellmann-Strobl, MD Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Jan-Markus Doerr No disclosure on file
Mareile Haertle No disclosure on file
Guillermo Povedano, MD No disclosure on file
Hanna Kolski, MD No disclosure on file
Lauren Morgenroth Ms. Morgenroth has received personal compensation for serving as an employee of TRiNDS. Ms. Morgenroth has stock in TRiNDS.
Doralina G. Souza No disclosure on file
Munish K. Goyal, MD, FAAN No disclosure on file
Ken Kubota No disclosure on file
William DeLeeuw No disclosure on file
Lorraine Ramig, PhD No disclosure on file
Rolf Martin No disclosure on file
Evanthia Bernitsas, MD, FAAN Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Daniel W. Miller, MD No disclosure on file
Kenneth Maravilla, MD No disclosure on file
Jill Miller-Horn, MD Dr. Miller-Horn has nothing to disclose.
Tejwant Bindra, MD No disclosure on file
Mary R. Andriola, MD, FAAN No disclosure on file
Ravi Patel, MD, MBA, FAHA No disclosure on file
Sushma Manda, MD No disclosure on file
Hugo A. Arroyo, MD Dr. Arroyo has nothing to disclose.
Mohammad Hirmand No disclosure on file
Richard C. Dodel, MD No disclosure on file
J.J. Van Hilten No disclosure on file
Mark Cohen Mark Cohen has nothing to disclose.
Ismail A. Khatri, MD, MBBS, FAAN Dr. Khatri has nothing to disclose.
Nicoline Schiess, MD Dr. Schiess has received personal compensation for serving as an employee of World Health Organization .
Dhairyawan Pokalkar, MD, FAAN No disclosure on file
Sydney Cash, MD Dr. Cash has received stock or an ownership interest from Beacon Biosignals.
Ioanna Chatzi No disclosure on file
Jennifer E. Fugate, DO Dr. Fugate has nothing to disclose.
Sarah Wahlster, MD Dr. Wahlster has nothing to disclose.
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Kiyonobu Komai, MD Dr. Komai has nothing to disclose.
Rachel Marie E. Salas, MD, MEd, FAAN Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Maria Saladino No disclosure on file
Christos Sidiropoulos, MD, FAAN Dr. Sidiropoulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PD Neurotechnology.
Richard Salazar, MD, FAAN No disclosure on file
Maureen A. Mealy, PhD, RN No disclosure on file
Kate T. Brizzi, MD Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Fern Health. Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon.
Seung-Hun Oh, MD No disclosure on file
Narupat Suanprasert No disclosure on file
Lan Qin, MD, PhD, FAAN No disclosure on file
Odinachi N. Oguh, MD Dr. Oguh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE . Dr. Oguh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion .
Ezequiel A. Piccione, MD, FAAN Dr. Piccione has nothing to disclose.
Santiago A. Vetere, MD No disclosure on file
Nicolas Mavroudakis, MD, PhD No disclosure on file
Amre Nouh, MD, FAAN Dr. Nouh has stock in Openwater.
Rodrigo Zepeda, MD The institution of Dr. Zepeda has received research support from NIH.
Ahmad Abulaban, MD, FAAN Dr. Abulaban has nothing to disclose.
Lan Tan No disclosure on file
Marcela Parada Marcilla, MD No disclosure on file
Jorge Blanche, MD No disclosure on file
Marcos G. Burgos, MD No disclosure on file
Margarita Moreno, MD No disclosure on file
Norma Deri, MD Norma Deri, MD has nothing to disclose.
Meiko Maeda, MD, PhD No disclosure on file
Jin-Tai Yu No disclosure on file
Ricardo Alonso Ricardo Alonso has nothing to disclose.
Vishal Shah, MBBS, FAAN Dr. Shah has nothing to disclose.
Beata Sliwinska No disclosure on file
Ronald L. Thibert, DO Dr. Thibert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Pharmaceuticals.
Serefnur Ozturk, MD No disclosure on file
David J. Paling, MD No disclosure on file
Virginia Laura Parisi, MD No disclosure on file
Farwa Ali, MD Dr. Ali has nothing to disclose.
Eric W. Piedade Pan No disclosure on file
Fernando Maestu Fernando Maestu has nothing to disclose.
Bruce Taylor Bruce Taylor has nothing to disclose.
Paola Fontanetti No disclosure on file
Lusine B. Kirakosyan, MD No disclosure on file
Abhimanyu Mahajan, MD, MHS, FAAN Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima Therapeutics, Inc.. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Mahajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adaptive Biosciences . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement disorders clinical practice. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Texas Alzheimer's Research And Care Consortium .
Chiseko Ikenaga, MD, PhD Dr. Ikenaga has nothing to disclose.
Harry Alexopoulos No disclosure on file
Khaled Abdel-Aziz, MD No disclosure on file
Rhian E. Raftopoulos, MBBS, PhD No disclosure on file
Sira Carrasco No disclosure on file
Melissa Elafros, MD, PhD The institution of Dr. Elafros has received research support from National Institute of Neurologic Disorders and Stroke . The institution of Dr. Elafros has received research support from National Center for Advancing Translational Sciences. The institution of Dr. Elafros has received research support from National Institute of Diabetes and Digestive and Kidney Diseases .
Lucia Rivera Lara, MD Dr. Rivera Lara has received personal compensation in the range of $5,000-$9,999 for serving as a expert witness with Legal firms.
Omar Siddiqi, MD The institution of Dr. Siddiqi has received research support from NIH.
Charlotte S. Herber No disclosure on file
Patrick A. Huott, MD No disclosure on file
John F. Ryan No disclosure on file
Edward C. Leung, MD No disclosure on file
Nicholas Davies No disclosure on file
Facundo Burgos Ruiz, Jr., MD No disclosure on file
Brigid Dwyer, MD Dr. Dwyer has nothing to disclose.
Annie S. Daniel, MBBS Dr. Daniel has nothing to disclose.
Nuttawan Vongveeranonchai, MD No disclosure on file
Niamh Cawley, MD No disclosure on file
Awss Zidan, MD An immediate family member of Dr. Zidan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ruham Nasany MD.
RAUL REY No disclosure on file
Nadia B. Ben Ali, PhD No disclosure on file
Letizia G. Borges, MD No disclosure on file
Nicholas Musso No disclosure on file
Priya Narwal, MD Dr. Narwal has nothing to disclose.
Freddy Alfaro-Martinez, MD No disclosure on file
Erica McKenzie, MD Dr. McKenzie has nothing to disclose.
Amareshwer Rao Katha, MD No disclosure on file
Jimmy B. Young, MD No disclosure on file
Alexandra Economou No disclosure on file
Nasrin Asgari Nasrin Asgari, 6560 has nothing to disclose.
Tali R. Sorets Tali R. Sorets has nothing to disclose.
Izukanje Sikazwe No disclosure on file
Carlos H. Ballario, MD No disclosure on file
Asha V. Kishore, MD No disclosure on file
Gagandeep Singh, MD Dr. Singh has nothing to disclose.
Gabriel D. Volman, MD No disclosure on file
Claudia Catarino No disclosure on file
Michael B. Russell No disclosure on file
Brent Johnson No disclosure on file
Rajinder Bansal, MD No disclosure on file
Graciela Arguello De Alday, MD No disclosure on file
Miguel Jacobo, MD No disclosure on file
Pearl K. Jones, MD No disclosure on file
Deema S. Al Rasheed, MD No disclosure on file
Rossana Neme, MD No disclosure on file
Alice D. Lam, MD, PhD Dr. Lam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurona Therapeutics. Dr. Lam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. The institution of Dr. Lam has received research support from Neurona Therapeutics. The institution of Dr. Lam has received research support from NIH. The institution of Dr. Lam has received research support from Alzheimer's Association.
Ramiro Linares, MD No disclosure on file
Andres Barboza, MD, PhD No disclosure on file
Patricio Labal, MD, PhD No disclosure on file
Birinder S. Paul, MD Dr. Paul has nothing to disclose.
Dearbhla Kelly, MD Dr. Kelly has nothing to disclose.
Maria Cerdan Sanchez No disclosure on file
Anna Grisold, MD No disclosure on file
James D. Triplett, MBBS Dr. Triplett has nothing to disclose.
Michael Ackerl, MD No disclosure on file
Geir Braathen No disclosure on file
Noel Cabanas No disclosure on file
Prasad Malladi No disclosure on file
Michael Stalder No disclosure on file
Martina Samiotaki No disclosure on file
Monika Singla, MBBS Dr. Singla has nothing to disclose.
Wei Xu No disclosure on file
Byeong Su Yim No disclosure on file